(Q40755896)

23 September 2017

title

Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer (English)

1 reference

23 September 2017

1 reference

Stein KD

1

1 reference

23 September 2017

Jacobsen PB

2

1 reference

23 September 2017

Hann DM

3

1 reference

23 September 2017

Greenberg H

4

1 reference

23 September 2017

Lyman G

5

1 reference

23 September 2017

publication date

1 June 2000

1 reference

Journal of Pain and Symptom Management

23 September 2017

published in

1 reference

23 September 2017

volume

19

1 reference

23 September 2017

issue

6

1 reference

23 September 2017

page(s)

436-445

1 reference

Hot flashes: epidemiology and physiology

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

A multidimensional measure of fatigue for use with cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Symptoms associated with tamoxifen treatment in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

10.1016/S0885-3924(00)00142-1

Identifiers

DOI

1 reference

23 September 2017

1 reference